z-logo
open-access-imgOpen Access
NK 1.1 − CD 4 + NKG 2D + T cells suppress DSS ‐induced colitis in mice through production of TGF ‐β
Author(s) -
Qian Xingxing,
Hu Chunxia,
Han Sen,
Lin Zhijie,
Xiao Weiming,
Ding Yanbing,
Zhang Yu,
Qian Li,
Jia Xiaoqing,
Zhu Guoqiang,
Gong Weijuan
Publication year - 2017
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.13072
Subject(s) - nkg2d , immune system , interleukin 12 , interleukin 21 , cytotoxic t cell , microbiology and biotechnology , immunology , chemistry , t cell , biology , biochemistry , in vitro
CD 4 + NKG 2D + T cells are associated with tumour, infection and autoimmune diseases. Some CD 4 + NKG 2D + T cells secrete IFN ‐γ and TNF ‐α to promote inflammation, but others produce TGF ‐β and FasL to facilitate tumour evasion. Here, murine CD 4 + NKG 2D + T cells were further classified into NK 1.1 − CD 4 + NKG 2D + and NK 1.1 + CD 4 + NKG 2D + subpopulations. The frequency of NK 1.1 − CD 4 + NKG 2D + cells decreased in inflamed colons, whereas more NK 1.1 + CD 4 + NKG 2D + cells infiltrated into colons of mice with DSS ‐induced colitis. NK 1.1 − CD 4 + NKG 2D + cells expressed TGF ‐β and FasL without secreting IFN ‐γ, IL ‐21 and IL ‐17 and displayed no cytotoxicity. The adoptive transfer of NK 1.1 − CD 4 + NKG 2D + cells suppressed DSS ‐induced colitis largely dependent on TGF ‐β. NK 1.1 − CD 4 + NKG 2D + cells did not expressed Foxp3, CD 223 ( LAG ‐3) and GITR . The subpopulation was distinct from NK 1.1 + CD 4 + NKG 2D + cells in terms of surface markers and RNA transcription. NK 1.1 − CD 4 + NKG 2D + cells also differed from Th2 or Th17 cells because the former did not express GATA ‐3 and ROR ‐γt. Thus, NK 1.1 − CD 4 + NKG 2D + cells exhibited immune regulatory functions, and this T cell subset could be developed to suppress inflammation in clinics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here